Expression of Lymphoid Enhancer‐Binding Factor 1 in Cancer‐Associated Fibroblasts Mediates Tumor Growth and Transdifferentiation Toward Squamous Cell Carcinoma in Human Breast Cancer
Hiroya Okazaki(Tokyo Dental College), Akira Orimo(University of Manchester), Yataro Daigo(The University of Tokyo), Akane Ishizuka(Juntendo University), Kazunori Kajino(The Cancer Institute Hospital), Tomoyuki Yokose(Kanagawa Prefectural Hospital Organization), Yang Shi(University of Victoria), Toshinari Yamashita(Kanagawa Prefectural Hospital Organization), Yoshihiro Mezawa(Juntendo University), Takehiro Yasukawa(Juntendo University), Yohei Miyagi(Kanagawa Cancer Center), Yuki Fukumura(Juntendo University), Kazunari Yamashita(Tohoku University), Akira Katakura(Tokyo Dental College), Zixu Wang(Dana-Farber Cancer Institute), Atsushi Takano(The University of Tokyo), Yu Koyama(Tokyo Dental College), Mizuki Sakimoto(Juntendo University)
Cited by 1
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593